市場調査レポート

商品コード

1722460

獣医分子診断市場レポート：製品タイプ、技術、動物タイプ、疾患タイプ、エンドユーザー、地域別、2025年～2033年

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033

出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 438,093円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 584,173円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 730,253円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

獣医分子診断の世界市場規模は2024年に7億4,560万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに14億8,220万米ドルに達し、2025年から2033年にかけて7.54%の成長率（CAGR）を示すと予測しています。大衆の間でのペット飼育の増加、分子診断技術の進歩の増加、獣医診療における分子診断検査を標準化するための厳格な規制ガイドラインと品質管理基準の導入の増加は、市場成長を促進する主な要因の一部です。

獣医分子診断市場分析：

主な市場促進要因：ペットの飼育数の増加は市場成長を促進する重要な要因の一つです。さらに、動物の感染因子を迅速かつ正確に検出できる分子診断に対する需要の高まりは、ヒトへの疾病感染を予防し、公衆衛生を守るのに役立ち、市場の成長を後押ししています。
主な市場動向：治療計画を調整し、病気のかかりやすさを予測するために、動物医療における個別化医療の利用が増加していることが、市場全体に明るい展望をもたらしています。
競合情勢：主要企業としては、Biochek B.V.、bioMerieux SA、HealthGene Corporation、Heska Corporation、IDEXX Laboratories Inc.、INDICAL BIOSCIENCE GmbH、Ingenetix GmbH、NEOGEN Corporation、Qiagen N.V.、Thermo Fisher Scientific Inc.、獣医分子診断Inc.、Zoetis Inc.などが挙げられます。
地理的動向：報告書によると、北米が最大の市場シェアを占めています。これは、大衆の間でペットとの交友を楽しむためにペットの導入が増加していることに起因しています。これに加えて、分子診断検査が手頃な価格で入手できるようになり、より広範な獣医療現場で実行可能な選択肢となっていることも、市場の成長に寄与しています。
課題と機会：獣医分子診断における課題には、費用対効果が高く使いやすい技術の必要性や、多様な動物種で精度を確保するための広範なバリデーションの必要性などがあります。治療機会は、タイムリーな診断のための迅速なポイント・オブ・ケアアッセイの開発、および遺伝子情報に基づく個別化治療計画の可能性にあり、動物医療を前進させる。

獣医分子診断市場動向：

大衆におけるペット飼育の拡大

ペットの大衆化が獣医分子診断市場にプラスの影響を与えています。このようなペット飼育の急増は、診断を含む獣医学的サービスに対する需要の増加をもたらしています。例えば、ペットフード製造業者協会が2021年3月に発表したペット人口データによると、英国では59%以上の世帯がペットを飼育しており、2021年には3,260万匹以上のペットが飼育されています。ペットを家族の一員として扱う傾向が強まっており、それが獣医分子診断市場の需要を増大させています。さらに、犬と猫はペットを飼う親に人気のあるペットです。例えば、犬の人口は2022年に約6億450万人であったのに対し、猫の人口は世界全体で約4億820万人でした。これに加えて、米国ペット用品協会は2022年4月に、米国のペット産業支出総額は2020年の1,036億米ドルから2021年には1,236億米ドルに達すると発表しました。ペットの飼い主のかなりの部分が動物の様々な病状に対して高度な診断方法を使用し、獣医分子診断市場の最近の価格を押し上げると予想されるため、動物医療支出の増加は獣医分子診断市場の成長を促進すると予想されます。

動物疾患の有病率の上昇

動物疾患の有病率の上昇が獣医分子診断市場の成長を後押ししています。2021年6月にカルガリー大学が発表した研究によると、人獣共通感染症における潜在的な役割を推測するために、家庭犬における多包虫エキノコックスの感染を調査するために実施されたもので、北半球（カナダ・アルバータ州）の寄生蠕虫である多包虫エキノコックスは、通常、定宿主と中間宿主を循環すると述べています。しかし都市部では、飼い犬もこの寄生虫の宿主になる可能性があり、その近接性からヒトへの重大なリスク要因になる可能性があります。このほかにも、毎年5頭に1頭の家畜が病気によって失われており、さらに多くの家畜が病気の影響を受けていると推定されています。Emerging Pathogen Institutesが2021年11月に発表した記事によると、牛呼吸器疾患は肥育牛の疾病の75％を占め、畜牛生産者の経済損失は毎年10億米ドルを超えています。結膜炎の推定コストは年間1億5,000万米ドルで、足腐病による酪農家の損失は1頭当たり120米ドルから350米ドルです。このような家畜の損失増加や遺伝的疾患は、獣医分子診断の需要を促進し、獣医分子診断市場シェアを拡大すると予想されます。

分子診断技術の進歩の増加

分子診断技術の進歩の増加が市場の成長を後押ししています。ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、マイクロアレイ解析などの最先端の分子診断技術は、獣医師に動物の健康に関する比類ない洞察を提供するために絶えず進化しています。さらに、様々な主要市場プレーヤーが、質の高い診断と治療を促進するために、改良された診断キットや機器を発売しています。例えば、2022年4月、グリーンズボロのCarolina Liquid Chemistries Corpは、米国獣医市場向けにポータブル分析器を販売する半独占契約を締結しました。同社が販売するSeamatySMT-120 VP動物用自動化学分析装置は、動物の健康診断用のコンパクトな全自動化学・電解質免疫測定・凝固分析装置です。同様に、2021年9月、Micro Vet Diagnostics社は、全く新しい動物用化学・電解質・免疫測定・凝固分析装置であるMicro-chem IIを発売し、正確な基準値と実験室品質の結果を得ることができます。このような技術革新により、動物検査室の効率が向上し、検査結果の迅速な提供が可能になり、今後数年間で獣医分子診断市場の収益が促進されると予想されます。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第12章 SWOT分析

概要
強み
弱み
機会
脅威

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第15章価格分析

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Biochek B.V.
- bioMerieux SA
- HealthGene Corporation
- Heska Corporation
- IDEXX Laboratories Inc.
- INDICAL BIOSCIENCE GmbH
- Ingenetix GmbH
- NEOGEN Corporation
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Zoetis Inc.

図表

List of Figures

Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2024
Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2024
Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2024
Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2024
Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2024
Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2024
Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2024
Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million USD), 2025-2033
Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players

Product Code: SR112025A5121

The global veterinary molecular diagnostics market size reached USD 745.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,482.2 Million by 2033, exhibiting a growth rate (CAGR) of 7.54% during 2025-2033. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the market growth.

Veterinary Molecular Diagnostics Market Analysis:

Major Market Drivers: Increasing pet ownership is one of the significant factors driving the growth of the market. Additionally, the rising demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health, is impelling the growth of the market.
Key Market Trends: The rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is creating a positive outlook for the overall market.
Competitive Landscape: Some of the leading veterinary molecular diagnostics companies include Biochek B.V., bioMerieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Inc., among others.
Geographical Trends: According to the report, North America accounted for the largest market share. This can be attributed to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market.
Challenges and Opportunities: Challenges in veterinary molecular diagnostics include the need for cost-effective and user-friendly technologies, as well as the requirement for extensive validation to ensure accuracy across diverse animal species. Opportunities lie in the development of rapid, point-of-care assays for timely diagnosis and the potential for personalized treatment plans based on genetic information, advancing animal health care.

Veterinary Molecular Diagnostics Market Trends:

Growing Adoption of Pets Among the Masses

The growing adoption of pets among the masses is positively influencing the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. For instance, according to the pet population data published in March 2021 by the Pet Food Manufacturers Association, over 59% of households in the United Kingdom had pets, with over 32.6 million pets in 2021. The trend of treating pets as family members is growing, which in turn is augmenting the veterinary molecular diagnostics market demand. Moreover, dogs and cats are the popular pets adopted by pet parents. For instance, the dog population was around 604.5 million in 2022, whereas the cat population was approx. 408.2 million globally. Besides this, the American Pet Products Association published in April 2022 that the total American pet industry expenditure reached US$ 123.6 Billion in 2021, up from US$ 103.6 Billion in 2020. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals and propel the veterinary molecular diagnostics market's recent price.

Rising Prevalence of Animal Diseases

The rising prevalence of animal diseases is bolstering the growth of the veterinary molecular diagnostics market. According to a study published by the University of Calgary in June 2021, conducted to investigate the infections of Echinococcus multilocularis in domestic dogs to infer their potential role in zoonotic transmission, stated that Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), normally cycles through definitive and intermediate hosts. But in urban areas, domestic dogs can also become hosts for this parasite, which could become a significant risk factor to humans due to their proximity. Besides this, it is estimated that one in five farm animals is lost due to diseases each year, while many more animals suffer the effects of illness. According to an article published by Emerging Pathogen Institutes in November 2021, bovine respiratory diseases account for 75% of feedlot illnesses, and economic losses to cattle producers exceed US$ 1 Billion every year. The estimated costs for pinkeye are US$ 150 Million yearly, and losses to dairy producers due to foot rot range from US$ 120 to US$ 350 per animal. Such increasing losses and genetic disorders among animals are expected to drive the demand for veterinary molecular diagnostics, thereby augmenting the veterinary molecular diagnostics market share.

Increasing Advancements in Molecular Diagnostic Technologies

The increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. Moreover, various key market players are launching improved diagnostics kits and instruments to facilitate quality diagnosis and treatments. For instance, in April 2022, Carolina Liquid Chemistries Corp of Greensboro signed a semi-exclusive agreement to distribute a portable analyzer for the US veterinary market. The company distributed the SeamatySMT-120 VP veterinary automated chemistry analyzer, a compact, fully automatic chemistry, electrolyte immunoassay, and coagulation analyzer for animal health diagnosis. Similarly, in September 2021, Micro Vet Diagnostics launched Micro-chem II, a completely new chemistry, electrolyte, immunoassay, and coagulation analyzer for animal health, producing accurate reference and laboratory-quality results. Such innovations are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results, which is anticipated to propel veterinary molecular diagnostics market revenue in the coming years.

Global Veterinary Molecular Diagnostics Industry Segmentation:

Breakup by Product:

Kits and Reagents
Instruments
Software and Services

Kits and reagents dominate the market

The veterinary molecular diagnostics market report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.

In veterinary molecular diagnostics, various kits and reagents are required to conduct tests and experiments to detect and analyze nucleic acids from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are employed to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility.

Breakup by Technology:

Real Time PCR
Microarray
DNA Sequencing

Real time PCR holds the largest share in the market

Real-time PCR (Polymerase Chain Reaction) in Veterinary Molecular Diagnostics is a molecular biology technique used to amplify and quantify DNA in real-time during the PCR process. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.

Breakup by Animal Type:

Companion Animal
Livestock Animal

Companion animal holds the biggest share in the market

As per the veterinary molecular diagnostics market statistics by IMARC, the increasing trend of pet humanization is contributing to the growth of this segment. Companion animals, like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. The rising pet ownership and growing consciousness of pet parents regarding the health of their pets are bolstering the market for molecular diagnostics. For instance, there are over 31 million pet dogs and around 2.44 million pet cats in India. The pet cat population may reach 4.89 million by 2026. 11% of people in India own at least four pets. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease.

Breakup by Disease Type:

Vector-borne Diseases
Respiratory Pathogens
Diarrhea Pathogens
Others

Vector-borne diseases hold the maximum share in the market

Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic methods, like PCR, swiftly and precisely identify the genetic material of pathogens causing vector-borne diseases in animals, crucial for efficient disease control. Such techniques aid in tracking disease advancement in infected animals, enabling veterinarians to gauge infection severity and adapt treatment strategies accordingly.

Breakup by End User:

Veterinary Hospitals
Clinical Laboratories
Research Institutes

The veterinary molecular diagnostics market overview indicates that veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.

Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Besides this, in research institutes focused on enhancing understanding of animal health, genetics, and disease mechanisms, veterinary molecular diagnostics is essential. Utilizing state-of-the-art molecular methods like Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, these institutes conduct diverse studies benefiting both animal and human welfare.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. For instance, according to pet ownership statistics by Forbes, pet ownership in the U.S. jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. That is up from 56% in 1988. Moreover, the rise in the prevalence of animal diseases and injuries is also a major factor bolstering the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), the annual expenditure on a routine visit for dogs accounts for US$ 242 and US$ 178 for cats in the country. Furthermore, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the escalating number of product launches in North America that focus on molecular diagnostics for animals drives the market growth. For instance, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Such activities are expected to positively impact the veterinary molecular diagnostics market outlook in the coming years.

Competitive Landscape:

Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Biochek B.V.
bioMerieux SA
HealthGene Corporation
Heska Corporation
IDEXX Laboratories Inc.
INDICAL BIOSCIENCE GmbH
Ingenetix GmbH
NEOGEN Corporation
Qiagen N.V
Thermo Fisher Scientific Inc.
Veterinary Molecular Diagnostics Inc.
Zoetis Inc.

Key Questions Answered in This Report

1.What was the size of the global veterinary molecular diagnostics market in 2024?
2.What is the expected growth rate of the global veterinary molecular diagnostics market during 2025-2033?
3.What are the key factors driving the global veterinary molecular diagnostics market?
4.What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
5.What is the breakup of the global veterinary molecular diagnostics market based on the product?
6.What is the breakup of the global veterinary molecular diagnostics market based on the technology?
7.What is the breakup of the global veterinary molecular diagnostics market based on the animal type?
8.What is the breakup of the global veterinary molecular diagnostics market based on the disease type?
9.What are the key regions in the global veterinary molecular diagnostics market?
10.Who are the key players/companies in the global veterinary molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Kits and Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Real Time PCR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Microarray
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Animal Type

8.1 Companion Animal
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Livestock Animal
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Disease Type

9.1 Vector-borne Diseases
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Respiratory Pathogens
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Diarrhea Pathogens
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by End User

10.1 Veterinary Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Clinical Laboratories
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Research Institutes
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Biochek B.V.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 bioMerieux SA
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
  - 16.3.2.4 SWOT Analysis
- 16.3.3 HealthGene Corporation
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Heska Corporation
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 IDEXX Laboratories Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 INDICAL BIOSCIENCE GmbH
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 Ingenetix GmbH
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 NEOGEN Corporation
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Qiagen N.V
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Thermo Fisher Scientific Inc.
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis
- 16.3.11 Veterinary Molecular Diagnostics Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
- 16.3.12 Zoetis Inc.
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis

獣医分子診断市場レポート：製品タイプ、技術、動物タイプ、疾患タイプ、エンドユーザー、地域別、2025年～2033年

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033

獣医分子診断市場分析：

獣医分子診断市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の獣医分子診断市場

第6章 市場内訳：製品別

第7章 市場内訳：技術別

第8章 市場内訳：動物タイプ別

第9章 市場内訳：疾患タイプ別

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

第16章 競合情勢